Showing 201 - 220 results of 61,917 for search '(( 05 0 decrease ) OR ( 50 ((((ns decrease) OR (nn decrease))) OR (we decrease)) ))', query time: 0.62s Refine Results
  1. 201

    Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

    Published 2025
    “…The data represents mean values and standard deviation, n = 3. <b>Legends:</b> ns: non-significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.…”
  2. 202

    The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

    Published 2020
    “…(F) The GluN2B-C456Y mutation decreases the sensitivity to glycine. <i>n</i> = 4 oocytes for WT (EC<sub>50</sub> = 0.38 ± 0.017 μM) and 9 oocytes for C456Y (EC<sub>50</sub> = 1.13 ± 0.049 μM), **<i>P</i> = 0.007, Mann-Whitney. …”
  3. 203
  4. 204

    Decreased phosphorylation of EIF2α underlies the impairment of arsenite-induced SG formation in LSM12-depleted cells. by Jongbo Lee (9914603)

    Published 2020
    “…Data represent means ± SEM (<i>n</i> = 3). n.s., not significant; *<i>P</i> < 0.05, **<i>P</i> < 0.01, as determined by Student <i>t</i> test. …”
  5. 205
  6. 206

    DataSheet_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.docx by Zijing Ran (11429935)

    Published 2021
    “…</p>Results<p>ULT resulted in a mean (standard deviation) decrease in SU level (464.22 ± 110.21 μmol/L at baseline, 360.93 ± 91.66 μmol/L at the final visit, p <0.001) accompanied by a decrease in median (interquartile range) VFA [97.30 (81.15–118.55) at baseline, 90.90 (75.85–110.05) at the final visit, p < 0.001]. …”
  7. 207
  8. 208

    Summary of trend results based on Mann-Kendall test and Sen’s slope estimator for the 34 weather stations (arranged according to administrative division, in bold) for the wet season (May to October), (<i>p</i> < 0.10 = *, <i>p</i> < 0.05 = **, <i>p</i> < 0.01 = ***,—sign indicates decreasing trend). by Mohammed Mainuddin (8723352)

    Published 2022
    “…<p>Summary of trend results based on Mann-Kendall test and Sen’s slope estimator for the 34 weather stations (arranged according to administrative division, in bold) for the wet season (May to October), (<i>p</i> < 0.10 = *, <i>p</i> < 0.05 = **, <i>p</i> < 0.01 = ***,—sign indicates decreasing trend).…”
  9. 209
  10. 210
  11. 211
  12. 212
  13. 213

    Cation Disorder and Large Tetragonal Supercell Ordering in the Li-Rich Argyrodite Li<sub>7</sub>Zn<sub>0.5</sub>SiS<sub>6</sub> by Bernhard T. Leube (5811647)

    Published 2022
    “…A tetragonal argyrodite with >7 mobile cations, Li<sub>7</sub>Zn<sub>0.5</sub>SiS<sub>6</sub>, is experimentally realized for the first time through solid state synthesis and exploration of the Li–Zn–Si–S phase diagram. …”
  14. 214

    Cation Disorder and Large Tetragonal Supercell Ordering in the Li-Rich Argyrodite Li<sub>7</sub>Zn<sub>0.5</sub>SiS<sub>6</sub> by Bernhard T. Leube (5811647)

    Published 2022
    “…A tetragonal argyrodite with >7 mobile cations, Li<sub>7</sub>Zn<sub>0.5</sub>SiS<sub>6</sub>, is experimentally realized for the first time through solid state synthesis and exploration of the Li–Zn–Si–S phase diagram. …”
  15. 215

    Cation Disorder and Large Tetragonal Supercell Ordering in the Li-Rich Argyrodite Li<sub>7</sub>Zn<sub>0.5</sub>SiS<sub>6</sub> by Bernhard T. Leube (5811647)

    Published 2022
    “…A tetragonal argyrodite with >7 mobile cations, Li<sub>7</sub>Zn<sub>0.5</sub>SiS<sub>6</sub>, is experimentally realized for the first time through solid state synthesis and exploration of the Li–Zn–Si–S phase diagram. …”
  16. 216
  17. 217
  18. 218
  19. 219

    Efficacy and Safety of Topical Loteprednol Etaponate 0.5% and Topical Dexamethasone 0.1% in Post Cataract Surgery in Iraqi Patients. .csv by Leqaa Taha (20141172)

    Published 2024
    “…</p><p dir="ltr"><b>Objectives:</b> This study compares the effect of <a href="" target="_blank">topical loteprednol etabonate 0.5% and dexamethasone 0.1% on intraocular pressure (IOP) in post-cataract surgery.…”
  20. 220